Vice President and Head, Diabetes R&D Center, Novo Nordisk, Inc.
Dr. von Herrath serves as Director of the Center for Type 1 Diabetes Research in addition to being a full Professor in the La Jolla Institute for Immunology. Dr. von Herrath’s research focuses on strategies to prevent type 1 diabetes through the induction of regulatory T cells.
Dr. von Herrath wrote his thesis in the field of Biochemistry and then received his M.D. in Medicine from the Freiburg Medical School in Freiburg, Germany in 1988. He did his residency work at the Freiburg Medical Center in the Internal Medicine/Immunology department and at the Diakonic Hospital’s Intensive Care Unit in Freiburg. For his postdoctoral work, Dr. von Herrath went to The Scripps Research Institute and worked in its Neuropharmacology and Immunology departments.
Dr. von Herrath is an editor and reviewer for numerous publications as well as being a member of the American Society of Clinical Investigator and a Council Member for the International Diabetes Society. In addition, he is an Adjunct Professor of Medicine at the University of California, San Diego. He is the recipient of the 2008 American Diabetes Association-Lilly Outstanding Scientist Achievements Award, the 2006 Grotzky Award from the Juvenile Diabetes Foundation International, the 2007-2012 Scholar Award from the Juvenile Diabetes Foundation, awarded the 2014 Langerhans-Preis – German Diabetes Foundation, and was ranked in 2014 as the #1 Juvenile Diabetes Expert by “Expertscape.”